BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31900513)

  • 1. The sensitivity, specificity, and diagnostic accuracy of whole-bone MRI for identifying skip metastases in appendicular osteosarcoma and Ewing sarcoma.
    Barnett JR; Gikas P; Gerrand C; Briggs TW; Saifuddin A
    Skeletal Radiol; 2020 Jun; 49(6):913-919. PubMed ID: 31900513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
    Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
    Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of skip metastases on whole bone MRI in high-grade bone sarcomas.
    Saifuddin A; Sharif B; Oliveira I; Kalus S; Barnett J; Pressney I
    Skeletal Radiol; 2020 Jun; 49(6):945-954. PubMed ID: 31919587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skip metastases in appendicular Ewing sarcoma: relationship to distant metastases at diagnosis, chemotherapy response and overall survival.
    Saifuddin A; Michelagnoli M; Pressney I
    Skeletal Radiol; 2023 Mar; 52(3):585-591. PubMed ID: 36100697
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Bosma SE; Vriens D; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Bloem JL
    Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percent slope analysis of dynamic magnetic resonance imaging for assessment of chemotherapy response of osteosarcoma or Ewing sarcoma: systematic review and meta-analysis.
    Kubo T; Furuta T; Johan MP; Adachi N; Ochi M
    Skeletal Radiol; 2016 Sep; 45(9):1235-42. PubMed ID: 27229874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy.
    Franzius C; Sciuk J; Daldrup-Link HE; Jürgens H; Schober O
    Eur J Nucl Med; 2000 Sep; 27(9):1305-11. PubMed ID: 11007511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Utility of 18FDG PET/CT Versus Bone Scan for Identification of Bone Metastases in a Pediatric Sarcoma Population and a Review of the Literature.
    Tal AL; Doshi H; Parkar F; Abraham T; Love C; Ye K; Yang R; Hoang B; Loeb D; Chou A; Geller D; Moadel R
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):52-58. PubMed ID: 32815877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours.
    Györke T; Zajic T; Lange A; Schäfer O; Moser E; Makó E; Brink I
    Nucl Med Commun; 2006 Jan; 27(1):17-24. PubMed ID: 16340719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skip metastases in high-grade intramedullary appendicular osteosarcoma: an indicator of more aggressive disease?
    Saifuddin A; Michelagnoli M; Pressney I
    Skeletal Radiol; 2021 Dec; 50(12):2415-2422. PubMed ID: 33990864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging.
    Vormoor B; Knizia HK; Batey MA; Almeida GS; Wilson I; Dildey P; Sharma A; Blair H; Hide IG; Heidenreich O; Vormoor J; Maxwell RJ; Bacon CM
    PLoS One; 2014; 9(1):e85128. PubMed ID: 24409320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: A rare case of Ewing's sarcoma and osteosarcoma at different sites 10 years apart.
    Hosalkar HS; Atanda A; Barroeta J; Torbert JT; Lackman RD
    Clin Orthop Relat Res; 2005 May; (434):273-7. PubMed ID: 15864064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma.
    Newman EN; Jones RL; Hawkins DS
    Pediatr Blood Cancer; 2013 Jul; 60(7):1113-7. PubMed ID: 23192939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors.
    Degnan AJ; Chung CY; Shah AJ
    Clin Imaging; 2018; 47():9-13. PubMed ID: 28806574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review.
    Kalus S; Saifuddin A
    Eur Radiol; 2019 Oct; 29(10):5700-5708. PubMed ID: 30915559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skip metastases in Ewing's sarcoma: a report of three cases.
    Davies AM; Makwana NK; Grimer RJ; Carter SR
    Skeletal Radiol; 1997 Jun; 26(6):379-84. PubMed ID: 9229423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
    Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H
    AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of diffusion-weighted MRI in the initial assessment of osseous sarcomas in children and adolescents.
    Alsharief AN; Martinez-Rios C; Hopyan S; Amirabadi A; Doria AS; Greer MC
    Pediatr Radiol; 2019 Aug; 49(9):1201-1208. PubMed ID: 31203404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI Identification of the Osseous Extent of Pediatric Bone Sarcomas.
    Thompson MJ; Shapton JC; Punt SE; Johnson CN; Conrad EU
    Clin Orthop Relat Res; 2018 Mar; 476(3):559-564. PubMed ID: 29529641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary bone tumors: percutaneous needle biopsy. Radiologic-pathologic study of 222 biopsies.
    Ayala AG; Zornosa J
    Radiology; 1983 Dec; 149(3):675-9. PubMed ID: 6580673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.